FI901645A0 - Menetelmä terapeuttisesti aktiivisten interfenyleeni-7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinianalogien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten interfenyleeni-7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinianalogien valmistamiseksi

Info

Publication number
FI901645A0
FI901645A0 FI901645A FI901645A FI901645A0 FI 901645 A0 FI901645 A0 FI 901645A0 FI 901645 A FI901645 A FI 901645A FI 901645 A FI901645 A FI 901645A FI 901645 A0 FI901645 A0 FI 901645A0
Authority
FI
Finland
Prior art keywords
aralkyl
aryl
interphenylene
lower alkyl
alkyl
Prior art date
Application number
FI901645A
Other languages
English (en)
Swedish (sv)
Other versions
FI97543C (fi
FI97543B (fi
Inventor
Raj Narain Misra
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI901645A0 publication Critical patent/FI901645A0/fi
Application granted granted Critical
Publication of FI97543B publication Critical patent/FI97543B/fi
Publication of FI97543C publication Critical patent/FI97543C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI901645A 1989-04-03 1990-04-02 Menetelmä terapeuttisesti aktiivisten interfenyleeni-7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinianalogien valmistamiseksi FI97543C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33407089A 1989-04-03 1989-04-03
US33407089 1989-04-03

Publications (3)

Publication Number Publication Date
FI901645A0 true FI901645A0 (fi) 1990-04-02
FI97543B FI97543B (fi) 1996-09-30
FI97543C FI97543C (fi) 1997-01-10

Family

ID=23305449

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901645A FI97543C (fi) 1989-04-03 1990-04-02 Menetelmä terapeuttisesti aktiivisten interfenyleeni-7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinianalogien valmistamiseksi

Country Status (28)

Country Link
EP (1) EP0391652B1 (fi)
JP (1) JP2989213B2 (fi)
KR (1) KR0160508B1 (fi)
CN (1) CN1028529C (fi)
AT (1) ATE119903T1 (fi)
AU (1) AU632797B2 (fi)
CA (1) CA2012267C (fi)
CY (1) CY1851A (fi)
CZ (1) CZ285656B6 (fi)
DD (1) DD293353A5 (fi)
DE (1) DE69017735T2 (fi)
DK (1) DK0391652T3 (fi)
EG (1) EG19080A (fi)
ES (1) ES2069682T3 (fi)
FI (1) FI97543C (fi)
HK (1) HK110495A (fi)
HU (2) HUT54368A (fi)
IE (1) IE67274B1 (fi)
IL (1) IL93771A (fi)
MX (1) MX20132A (fi)
MY (1) MY106245A (fi)
NO (1) NO177425C (fi)
NZ (1) NZ232897A (fi)
PL (1) PL164345B1 (fi)
PT (1) PT93641B (fi)
RU (1) RU2059618C1 (fi)
SK (1) SK278865B6 (fi)
ZA (1) ZA902559B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
CA2081679A1 (en) * 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5281716A (en) * 1992-06-18 1994-01-25 Bristol-Myers Squibb Company Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6369089B1 (en) 2000-09-14 2002-04-09 Allergan Sales, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US7045634B2 (en) 2003-09-05 2006-05-16 Allergan, Inc. Prostamide receptor antagonists
US20100256385A1 (en) 2009-04-02 2010-10-07 Allergan, Inc. Prostaglandin e receptor antagonists
CA2837300A1 (en) * 2011-05-25 2012-11-29 Allergan, Inc. Fatty acid amide hydrolase inhibitors for treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652576A (en) * 1985-10-18 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
ZA899868B (en) * 1988-12-23 1990-09-26 Squibb & Sons Inc 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
IL93771A0 (en) 1990-12-23
NO177425C (no) 1995-09-20
DE69017735D1 (de) 1995-04-20
SK158290A3 (en) 1998-04-08
NO901494L (no) 1990-10-04
CA2012267C (en) 2001-02-27
MX20132A (es) 1994-01-31
FI97543C (fi) 1997-01-10
PL284600A1 (en) 1991-01-14
HU9002048D0 (en) 1990-08-28
EG19080A (en) 1994-07-30
NO177425B (no) 1995-06-06
AU5206490A (en) 1990-10-04
CY1851A (en) 1996-03-08
PT93641A (pt) 1990-11-20
IL93771A (en) 1995-06-29
MY106245A (en) 1995-04-29
CA2012267A1 (en) 1990-10-03
HUT54368A (en) 1991-02-28
ZA902559B (en) 1991-01-30
CN1046163A (zh) 1990-10-17
ATE119903T1 (de) 1995-04-15
CZ285656B6 (cs) 1999-10-13
PT93641B (pt) 1996-06-28
JP2989213B2 (ja) 1999-12-13
JPH02289579A (ja) 1990-11-29
DD293353A5 (de) 1991-08-29
PL164345B1 (pl) 1994-07-29
NZ232897A (en) 1992-12-23
RU2059618C1 (ru) 1996-05-10
EP0391652A1 (en) 1990-10-10
KR900016197A (ko) 1990-11-12
CN1028529C (zh) 1995-05-24
AU632797B2 (en) 1993-01-14
IE67274B1 (en) 1996-03-20
DK0391652T3 (da) 1995-04-03
NO901494D0 (no) 1990-04-02
HU210713A9 (en) 1995-06-28
IE901095L (en) 1990-10-03
EP0391652B1 (en) 1995-03-15
HK110495A (en) 1995-07-14
KR0160508B1 (ko) 1998-12-01
FI97543B (fi) 1996-09-30
ES2069682T3 (es) 1995-05-16
CZ158290A3 (cs) 1999-06-16
DE69017735T2 (de) 1995-08-17
SK278865B6 (sk) 1998-04-08

Similar Documents

Publication Publication Date Title
FI901645A0 (fi) Menetelmä terapeuttisesti aktiivisten interfenyleeni-7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinianalogien valmistamiseksi
FI932445A0 (fi) Farmaceutiska foereningar
MA20770A1 (fr) Nouveaux acides quinolone-carboxyliques substitues a substituant diazabicycloalkyle ponte
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
EP0535928A3 (en) Process for producing intermediates for use in production of alkoxyiminoacetamides and intermediates to be used therein
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
FI98125B (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
ES2094742T3 (es) Aminocarbonilcarbamatos relacionados con fisostigmina, un procedimiento para su preparacion y su uso como medicamentos.
PT89677A (pt) Processo para a preparacao de novos derivados azaciclicos, em particular derivados de piperidina
PT86032A (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung
DK707988A (da) Fremgangsmaade til at haemme virus
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ES2061749T3 (es) Compuestos heterociclicos y agentes antiulcerosos.
GR3015704T3 (en) Glycerin derivative and its pharmacological use.
DE69014261D1 (de) N-Azabicyclo[3.3.0]octanamide von aromatischen Säuren.
DE3887426D1 (de) Eperisone als Hypotonikum.
ES2058253T3 (es) Metodo para producir derivados de indano.
ATE35679T1 (de) Verfahren zur herstellung von cis-3,3,5trimethylcyclohexyl-d,l-alpha-(3-pyridincarboxy - phenylacetat.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: E.R. SQUIBB & SONS, INC.

MA Patent expired